ArticleTrials2024

IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS).

Hannah Preßler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.